Abstract
Background: Bortezomib
Disclosures
Corso:Janssen-Cilag: Honoraria.
Skip Nav Destination
653. Myeloma: Therapy, excluding Transplantation|
December 2, 2016
Impact of Switching from Intravenous to Subcutaneous Bortezomib in Real Life. Overlapping Toxicity and Efficacy in All Settings of Myeloma Patients Balancing Schedule and Way of Bortezomib Adminisration
Silvia Mangiacavalli, MD,
Silvia Mangiacavalli, MD
*
1Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
Search for other works by this author on:
Federica Cocito, MD,
Federica Cocito, MD
*
2Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, PAVIA, ITA
Search for other works by this author on:
Virginia Valeria Ferretti, PhD,
Virginia Valeria Ferretti, PhD
*
3Department of Hematology and Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
Search for other works by this author on:
Claudio Salvatore Cartia, MD,
Claudio Salvatore Cartia, MD
*
3Department of Hematology and Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
Search for other works by this author on:
Maya Ganzetti, MD,
Maya Ganzetti, MD
*
4Departement of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
Search for other works by this author on:
Mario Cazzola, MD,
Mario Cazzola, MD
5Departments of Hematology Oncology & Molecular Medicine, Fondazione IRCCS Policlinico San Matteo & University of Pavia, Pavia, Italy
Search for other works by this author on:
Alessandro Corso, MD
Alessandro Corso, MD
*
6Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
Search for other works by this author on:
Blood (2016) 128 (22): 5695.
Citation
Silvia Mangiacavalli, Federica Cocito, Virginia Valeria Ferretti, Claudio Salvatore Cartia, Maya Ganzetti, Mario Cazzola, Alessandro Corso; Impact of Switching from Intravenous to Subcutaneous Bortezomib in Real Life. Overlapping Toxicity and Efficacy in All Settings of Myeloma Patients Balancing Schedule and Way of Bortezomib Adminisration. Blood 2016; 128 (22): 5695. doi: https://doi.org/10.1182/blood.V128.22.5695.5695
Download citation file:
December 2 2016
Advertisement
Cited By
Advertisement
This feature is available to Subscribers Only
Sign In or Create an Account Close Modal